Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05287204 · ClinicalTrials.gov registry record
Critical Illness Myopathy and Trajectory of Recovery in AKI Requiring CRRT
A clinical trial of Acute Kidney Injury and Dialysis; Complications, sponsored by University of Iowa.
- Active
- Registry status
- 10
- Enrollment target
- 3
- Study locations
NCT05287204: Active study of Acute Kidney Injury and Dialysis; Complications, sponsored by University of Iowa.
NCT05287204 is a study of Acute Kidney Injury and Dialysis; Complications that is active but no longer recruiting, run by University of Iowa. The registered enrollment target is 10 participants, below the 2,331-participant average among 74 other Acute Kidney Injury trials with a reported enrollment target (100% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05287204, a study of Acute Kidney Injury and Dialysis; Complications, is active but no longer recruiting, sponsored by University of Iowa.
- ACTIVE NOT RECRUITING
- Registry status
- 10 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this study is to determine whether patients with acute kidney injury requiring renal replacement therapy have a higher incidence of muscle wasting than controls and whether the course of recovery is longer compared to controls.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Musculoskeletal ultrasound
- DIAGNOSTIC_TEST Assessments of muscle strength and physical function
- DIAGNOSTIC_TEST Metabolomics
Study Locations (3)
Iowa
- University of Iowa - Iowa City
Kentucky
- University of Kentucky - Lexington
New Mexico
- University of New Mexico - Albuquerque
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2021-11-29 |
| Est. Completion | 2024-12-30 |
What the registry record for NCT05287204 still lists
NCT05287204 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 2,331-participant average among 74 other Acute Kidney Injury trials with a reported enrollment target (100% lower).
The record links to 3 conditions, with Acute Kidney Injury appearing as the primary indexed condition, and to 3 interventions - of which Musculoskeletal ultrasound is the first listed.
NCT05287204 reports a single indexed study location in Iowa, Kentucky, New Mexico.
Frequently Asked Questions
What is clinical trial NCT05287204 about?
NCT05287204 is a clinical study titled "Critical Illness Myopathy and Trajectory of Recovery in AKI Requiring CRRT". The purpose of this study is to determine whether patients with acute kidney injury requiring renal replacement therapy have a higher incidence of muscle wasting than controls and whether the course of recovery is longer compared to controls.
What is the current status of trial NCT05287204?
This trial is currently active not recruiting. The enrollment target is 10 participants. The study started on 2021-11-29. Estimated completion is 2024-12-30.
What conditions does trial NCT05287204 study?
This clinical trial studies the following conditions: Acute Kidney Injury, Dialysis; Complications, Critical Illness Myopathy.
What interventions are being tested in trial NCT05287204?
The interventions under investigation include: Musculoskeletal ultrasound (DIAGNOSTIC_TEST), Assessments of muscle strength and physical function (DIAGNOSTIC_TEST), Metabolomics (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05287204?
This trial is sponsored by University of Iowa, which has 228 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05287204 being conducted?
This trial has 3 study locations across Iowa, Kentucky, New Mexico. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Kidney Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05287204's enrollment target sits among peer trials
10 74th of 74 the lowest of 74 other Acute Kidney Injury trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Acute Kidney Injury trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ultra-Low Contrast Angiography in AKI
RECRUITING · Phase 3
-
Novel Treatments in Improving Renal Outcomes in Light Chain Cast Nephropathy
RECRUITING
-
Physiologic Signals and Signatures With the Accuryn Monitoring System - The Accuryn Registry
RECRUITING
-
Droxidopa to Increase Mean Arterial Pressure in Decompensated Cirrhosis Patients With Acute Kidney Injury
RECRUITING · Phase 2
-
Theophylline Prophylaxis During Hypothermia to Limit Neonatal Nephron Damage
RECRUITING · Phase 1
-
Groundbreaking Renal Assist Device Intervening to ENhance cardioThoracic Surgery Outcomes
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI